The University of Chicago Header Logo

Connection

David Grdina to Receptor, ErbB-2

Back to Details
This is a "connection" page, showing publications David Grdina has written about Receptor, ErbB-2.
David Grdina
Connection Strength
0.156
Receptor, ErbB-2
  1. Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells. Nat Commun. 2020 09 14; 11(1):4591.
    View in: PubMed
    Score: 0.156
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.